Yousuf, M., Fathima, S., Alsugair, A., Wu, S., Abdelmagid, M., Faldu, P., Abdelaziz, R., Csizmar, C. M., Mangaonkar, A. A., Mendoza, C. J. Z., Reichard, K., Viswanatha, D., He, R., Pardanani, A. D., Gangat, N., Patnaik, M., Tefferi, A. (2026). One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: Co-mutation patterns and prognostic correlates.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6588